Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.

Mr. Fei  Long

Pavadinimas	Rinkos kapitalizacija
Lincoln National Corporation	0M
Atlantic American Corporation	0M
China Taiping Insurance Holdings Company Limited	0M
MetLife, Inc.	0M
Prudential plc	0M
Japan Post Insurance Co., Ltd.	0M
Migdal Insurance and Financial Holdings Ltd.	0M
Prudential plc	0M
PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk	0M
Yunfeng Financial Group Limited	0M
New China Life Insurance Company Ltd.	0M

Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd. Konkurentų sąrašas

Pagrindiniai konkurentai